<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02593565</url>
  </required_header>
  <id_info>
    <org_study_id>VCRC 5532</org_study_id>
    <nct_id>NCT02593565</nct_id>
  </id_info>
  <brief_title>Vasculitis Pregnancy Registry</brief_title>
  <acronym>V-PREG</acronym>
  <official_title>The Vasculitis Pregnancy Registry (V-PREG)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of South Florida</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Pennsylvania</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to learn about the experience of women with vasculitis who
      become pregnant. In particular, the study will consist of several online surveys to assess

        1. each woman's vasculitis severity and pregnancy-related experiences, and

        2. pregnancy outcomes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will consist of several on-line surveys to assess each woman's vasculitis severity,
      pregnancy-related experiences, and pregnancy outcomes. Participants will be asked to complete
      questionnaires at study entry, during the second trimester, during the third trimester, and
      postpartum. Investigators estimate that it will take approximately 20 minutes to complete
      each survey.

      All women enrolled in the Vasculitis Patient-Powered Research Network (V-PPRN) (with
      specified disease, sex, and age inclusion criteria described below) will be invited via email
      to participate in this on-line study. The survey data will be stored by the Data Management
      and Coordinating Center (DMCC) at the University of South Florida. Upon conclusion of the
      study period, the data will be sent to the Study Chairs.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2015</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>Unique pregnancy characteristics among women with vasculitis.</measure>
    <time_frame>Four years</time_frame>
    <description>To understand pregnancy characteristics and outcomes among women with vasculitis using patient-reported questionnaires in each trimester.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Vasculitis</condition>
  <condition>Behcet's Disease</condition>
  <condition>CNS Vasculitis</condition>
  <condition>Cryoglobulinemic Vasculitis</condition>
  <condition>Eosinophilic Granulomatosis With Polyangiitis (EGPA)</condition>
  <condition>Churg-Strauss Syndrome (CSS)</condition>
  <condition>Granulomatosis With Polyangiitis (GPA)</condition>
  <condition>Wegener's Granulomatosis</condition>
  <condition>IgA Vasculitis</condition>
  <condition>Henoch-Schoenlein Purpura (HSP)</condition>
  <condition>Microscopic Polyangiitis (MPA)</condition>
  <condition>Polyarteritis Nodosa (PAN)</condition>
  <condition>Takayasu Arteritis (TAK)</condition>
  <condition>Urticarial Vasculitis</condition>
  <condition>Systemic Vasculitis</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <description>Woman, 18 years of age or older, currently pregnant, and have a diagnosis of vasculitis.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Online questionnaires</intervention_name>
    <description>Women will be asked to complete questionnaires during their pregnancy and a postpartum questionnaire.</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Women with vasculitis who are currently pregnant.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Women 18 years of age or older with one of the following diseases may take part in the
             study:

               -  Behcet's disease;

               -  CNS vasculitis;

               -  cryoglobulinemic vasculitis;

               -  eosinophilic granulomatosis with polyangiitis (Churg-Strauss);

               -  granulomatosis with polyangiitis (Wegener's);

               -  IgA vasculitis (Henoch-Schoenlein purpura);

               -  microscopic polyangiitis;

               -  polyarteritis nodosa;

               -  Takayasu's arteritis;

               -  urticarial vasculitis.

          2. Women must be pregnant (self-report) at the time of enrollment into the registry.

        Exclusion Criteria:

          1. Non-English speaking.

          2. Unable to provide consent.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Megan Clowse, MD, MPH</last_name>
    <role>Study Chair</role>
    <affiliation>Duke University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Peter A Merkel, MD, MPH</last_name>
    <role>Study Chair</role>
    <affiliation>University of Pennsylvania</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Cristina Burroughs</last_name>
    <email>networkmanager@vpprn.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Carol McAlear, MA</last_name>
    <email>cmcalear@upenn.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of South Florida Data Management and Coordinating Center</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cristina Burroughs</last_name>
      <email>networkmanager@vpprn.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://vpprn.org</url>
    <description>The Vasculitis Patient-Powered Research Network</description>
  </link>
  <reference>
    <citation>Clowse ME, Richeson RL, Pieper C, Merkel PA; Vasculitis Clinical Research Consortium. Pregnancy outcomes among patients with vasculitis. Arthritis Care Res (Hoboken). 2013 Aug;65(8):1370-4. doi: 10.1002/acr.21983.</citation>
    <PMID>23401494</PMID>
  </reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 26, 2015</study_first_submitted>
  <study_first_submitted_qc>October 29, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 2, 2015</study_first_posted>
  <last_update_submitted>April 30, 2018</last_update_submitted>
  <last_update_submitted_qc>April 30, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 1, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Purpura</mesh_term>
    <mesh_term>Vasculitis</mesh_term>
    <mesh_term>Arteritis</mesh_term>
    <mesh_term>Systemic Vasculitis</mesh_term>
    <mesh_term>Behcet Syndrome</mesh_term>
    <mesh_term>Granulomatosis with Polyangiitis</mesh_term>
    <mesh_term>Microscopic Polyangiitis</mesh_term>
    <mesh_term>Takayasu Arteritis</mesh_term>
    <mesh_term>Aortic Arch Syndromes</mesh_term>
    <mesh_term>Churg-Strauss Syndrome</mesh_term>
    <mesh_term>Purpura, Schoenlein-Henoch</mesh_term>
    <mesh_term>Polyarteritis Nodosa</mesh_term>
    <mesh_term>Vasculitis, Central Nervous System</mesh_term>
    <mesh_term>Cryoglobulinemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

